Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AMRN
Vascepa--priority review in Canada:
https://www.newswire.ca/news-releases/hls-therapeutics-granted-priority-review-status-from-health-canada-for-vascepa-r--809869855.html
What a day for my biotech portfolio.
LOL LOL LOL
MRKR
On MRKR call, they said that the pancreatic trial has demonstrated some “very exciting clinical results” even though the product they used is not target optimized. And the clinical trial has enrolled/is enrolling rapidly as a result.
Hmmm
VKTX
More evidence that Viking's agent is best in class:
https://www.bloomberg.com/news/articles/2019-03-27/viking-therapeutics-climbs-after-fatty-liver-disease-results
No press release from the company?
Yeah I'm aware of those tricks. What is more concerning to me is the fact that a random user who looks up a stock ticker will see, at least for less prominent stocks, a giant pile of junk with only an occasional relevant article. The ratio is literally 20:1 for small biotechs. Yahoo's news feed has become almost unusable as well between the sponsored articles and the computer-generated junk.
Just frustrated today--it's like everything is proactively designed to waste my time and I am well known for being terribly impatient
Is anyone else becoming annoyed with those computer-generated nonsense articles that Google promotes as "top news"? Clearly a flaw in their algorithm; it's been proliferating to the point where for some stocks legitimate news gets buried within hours by a pile of garbage.
Who is behind these articles? Why do they bother?
Some of the many sites I'm talking about:
Regants Global Market
Financial Mercury
Simply Wall Street
iWatch Markets
MONReport
NMSU News
You understand that these articles are computer generated?
Why on earth would you expect IVIG to do anything if AD has a viral etiology.
PS that was for dew
Re CNAT
Is anyone here really surprised that these trials failed?
Alzheimer's, unfortunately, is a nearly impossible target to address. As much as I'd love to see an effective treatment that's one place I'd never put my money.
I do find the market action on MRKR hilarious though. I just had a partial fill of 31 shares. Who sells 31 shares of a $6 stock?
Re MRKR
That is not inaccurate....but let’s hope he’s not a teacher
I think the point here is that the technology is novel and a pretty remarkable advance over what we have now, which is essentially ex vivo gene therapy that addresses a single marker like CD19 and is consequently easy to escape from. And super expensive and highly toxic.
The great thing is that we can already be confident that the technology works in hematologic malignancy. So we have that regardless. If it works in solid tumors it would be the biggest advance in solid rumor management in decades. Guess we’ll see in a few months. I am cautiously optimistic...I’d be more excited if the trial wasn’t in the single deadliest tumor around.
I just don’t understand how this is flying completely under the radar...in a way I’m grateful because I’m not done accumulating. Hopefully I’ll get at least another couple quarters to build my position.
MRKR
10K is worth reading:
https://fintel.io/doc/sec-mrkr-marker-therapeutics-10k-2019-march-15-17970
Call March 28:
https://www.markertherapeutics.com/2019/03/marker-therapeutics-to-host-business-update-conference-call-and-webcast-on-thursday-march-28th/
The main problem for me with MRKR is that it is very thinly traded. Even a relatively small fish like me is having trouble accumulating without moving it significantly.
And this is a quote I just found from "Phantom Lord" on the MRKR board that will save me some typing. Just looking through his old posts he is quite impressively knowledgeable.